We are an Indo-US translational Biology Company focused on “Patient Segregation” in the area of cancer research. One of our core technologies was developed at Dana Faber Cancer Institute, Boston. Our R&D centre is located in Bangalore, India
To develop personalized treatment option for cancer based on detailed
molecular characterization and identification of key drivers of cancer progression and metastasis.
To enable rational design of clinical trials with high rate of success.
To become a top three biotechnology company in India by 2015.
To become a top five biotechnology company in the world by 2020.
To be a friend for the key stake holders in cancer treatment- Patients, Physicians and Pharmaceutical Companies.
To enhance the quality of life of patient by selecting the most optimal treatment plan.
To cut down drug development cost and time by identifying right drug combinations, and right patients for the drugs under development.